Publication | Closed Access

Lower Risk of Infectious Deaths in Cardiac Transplant Patients Receiving Basiliximab Versus Anti-thymocyte Globulin as Induction Therapy

Heart FailureTransplantationInfectious DeathsHematologyImmunologyLower RiskGraft SurvivalGraft RejectionCardiac Transplant PatientsImmunotherapyMedicineCell TransplantationHeart Transplantation